Skip to main content

Best Practices for Communicating Nitrosamine Strategies Between Makers and Users

Nitrosamines and related compounds continue to be a hot topic among regulatory agencies globally.

Regulators are asking drug product manufacturers to identify products at risk of N-nitrosamine formation or contamination, which could impact the pharmaceutical industry supply chain.

You can access this item by buying entire course

Buy entire course: